These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 39252049)

  • 1. Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes with coexisting nemaline myopathy: a case report.
    Gunawardena K; Praveenan S; Dissanayake VHW; Ratnayake P
    J Med Case Rep; 2024 Sep; 18(1):420. PubMed ID: 39252049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological features of patients with nemaline myopathy.
    Yin X; Pu CQ; Wang Q; Liu JX; Mao YL
    Mol Med Rep; 2014 Jul; 10(1):175-82. PubMed ID: 24788569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria: role of citrulline and arginine supplementation in MELAS syndrome.
    El-Hattab AW; Emrick LT; Chanprasert S; Craigen WJ; Scaglia F
    Int J Biochem Cell Biol; 2014 Mar; 48():85-91. PubMed ID: 24412347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders.
    El-Hattab AW; Emrick LT; Craigen WJ; Scaglia F
    Mol Genet Metab; 2012 Nov; 107(3):247-52. PubMed ID: 22819233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation.
    El-Hattab AW; Hsu JW; Emrick LT; Wong LJ; Craigen WJ; Jahoor F; Scaglia F
    Mol Genet Metab; 2012 Apr; 105(4):607-14. PubMed ID: 22325939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MELAS: a nationwide prospective cohort study of 96 patients in Japan.
    Yatsuga S; Povalko N; Nishioka J; Katayama K; Kakimoto N; Matsuishi T; Kakuma T; Koga Y;
    Biochim Biophys Acta; 2012 May; 1820(5):619-24. PubMed ID: 21443929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome.
    Sproule DM; Kaufmann P
    Ann N Y Acad Sci; 2008 Oct; 1142():133-58. PubMed ID: 18990125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children.
    Uusimaa J; Moilanen JS; Vainionpää L; Tapanainen P; Lindholm P; Nuutinen M; Löppönen T; Mäki-Torkko E; Rantala H; Majamaa K
    Ann Neurol; 2007 Sep; 62(3):278-87. PubMed ID: 17823937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population prevalence of the MELAS A3243G mutation.
    Manwaring N; Jones MM; Wang JJ; Rochtchina E; Howard C; Mitchell P; Sue CM
    Mitochondrion; 2007 May; 7(3):230-3. PubMed ID: 17300999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MELAS and L-arginine therapy.
    Koga Y; Akita Y; Nishioka J; Yatsuga S; Povalko N; Katayama K; Matsuishi T
    Mitochondrion; 2007; 7(1-2):133-9. PubMed ID: 17276739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction in MELAS improved by l-arginine supplementation.
    Koga Y; Akita Y; Junko N; Yatsuga S; Povalko N; Fukiyama R; Ishii M; Matsuishi T
    Neurology; 2006 Jun; 66(11):1766-9. PubMed ID: 16769961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.
    Scaglia F; Northrop JL
    CNS Drugs; 2006; 20(6):443-64. PubMed ID: 16734497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox".
    Naini A; Kaufmann P; Shanske S; Engelstad K; De Vivo DC; Schon EA
    J Neurol Sci; 2005 Mar; 229-230():187-93. PubMed ID: 15760638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-arginine improves the symptoms of strokelike episodes in MELAS.
    Koga Y; Akita Y; Nishioka J; Yatsuga S; Povalko N; Tanabe Y; Fujimoto S; Matsuishi T
    Neurology; 2005 Feb; 64(4):710-2. PubMed ID: 15728297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of nemaline myopathy cases with skeletal muscle alpha-actin gene mutations.
    Agrawal PB; Strickland CD; Midgett C; Morales A; Newburger DE; Poulos MA; Tomczak KK; Ryan MM; Iannaccone ST; Crawford TO; Laing NG; Beggs AH
    Ann Neurol; 2004 Jul; 56(1):86-96. PubMed ID: 15236405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes.
    Chomyn A; Enriquez JA; Micol V; Fernandez-Silva P; Attardi G
    J Biol Chem; 2000 Jun; 275(25):19198-209. PubMed ID: 10858457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous presentation in A3243G mutation in the mitochondrial tRNA(Leu(UUR)) gene.
    Koga Y; Akita Y; Takane N; Sato Y; Kato H
    Arch Dis Child; 2000 May; 82(5):407-11. PubMed ID: 10799437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population.
    Majamaa K; Moilanen JS; Uimonen S; Remes AM; Salmela PI; Kärppä M; Majamaa-Voltti KA; Rusanen H; Sorri M; Peuhkurinen KJ; Hassinen IE
    Am J Hum Genet; 1998 Aug; 63(2):447-54. PubMed ID: 9683591
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.